On which stock exchange is Marker's shares traded and what is the ticker symbol?

Marker Therapeutics, Inc.’s common stock is listed on the Nasdaq Capital Market under the ticker symbol “MRKR”.

When did Marker Therapeutics go public?

The company changed its name from TapImmune Inc. to Marker Therapeutics, Inc. on October 17, 2018.

Where is the Company headquartered?

The Company is headquartered in Houston, TX.

Where is the Company incorporated?

Marker Therapeutics is incorporated under the laws of the state of Delaware.

Who makes up Marker's Management, Board of Directors, and Scientific Advisory Board?

You can view the Management, Board of Directors, and Scientific Advisory Board by visiting our website.

What is Marker's fiscal year?

Marker’s fiscal year end is December 31.

What is the CUSIP number for Marker's shares?

The CUSIP number is 57055L 107.

How can I view documents Marker Therapeutics has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?

Quarterly & Annual Reports and other investor materials are available under Financial Filings of the Investors section of our website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.

 

How can I stay up to date with current news/annoucements of the company?

You can join the MRKR VIP list here. You will receive updates of the company. straight to your inbox. Also, you can follow us on Facebook, Twitter, and LinkedIn.